SCM
HCAT icon

Stonepine Capital Management’s Health Catalyst HCAT Stock Holding History

Stonepine Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-155,551
Closed -$443K – 76
2025
Q3 		$443K Buy
155,551
+55,551
+56% +$190K 0.36% 42
2025
Q2 		$377K Buy
+100,000
New +$393K 0.37% 46

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stonepine Capital Management's HCAT Position: Q4 2025 in Review

Stonepine Capital Management sold out of Health Catalyst (HCAT) in Q4 2025, closing a stake of 155,551 shares — an estimated $443K sold.

Stonepine Capital Management first reported a position in HCAT in Q2 2025 and held it in 2 quarters. The position peaked at $443K in Q3 2025. 136 funds tracked by Wall St. Rank hold HCAT as of Q4 2025.

  • Stonepine Capital Management reported no remaining Health Catalyst position as of Q4 2025 after selling out during the quarter.
  • Stonepine Capital Management sold 155,551 Health Catalyst shares in Q4 2025, an estimated $443K.
  • Stonepine Capital Management first reported a position in Health Catalyst in Q2 2025 and held it in 2 quarters.
  • Stonepine Capital Management's Health Catalyst position peaked at $443K in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2025.

Based on Stonepine Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.